ArticleMedicine2025
Differing MODY subtypes in a single family: A case report on monogenic diabetes, a CARE-compliant article.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
rationaleMature Onset Diabetes of the Young (MODY) is a monogenic form of diabetes that presents distinct diagnostic challenges due to its clinical similarities with type 1 and type 2 diabetes. MODY results from specific genetic mutations affecting pancreatic beta cell function, and its inheritance pattern is autosomal dominant. This case report details a unique instance of differing MODY types within a single family, highlighting the diagnostic complexity and genetic variability of the disease. PATIENT CONCERNS: A 58-year-old male patient with unexplained hypercholesterolemia and hyperglycemia. DIAGNOSES: He was diagnosed with MODY type 1 by subsequent genetic testing revealing a mutation in the hepatic nuclear factor 4 alpha gene.
interventionsTreatment with glimepiride led to significant improvements in his metabolic profile. OUTCOMES: The patient's diagnosis prompted genetic testing of his only child, who was found to have a different form of MODY, type 2, associated with a glucokinase gene mutation. This finding of differing MODY subtypes within one family is particularly noteworthy, given the typically consistent genetic transmission of MODY. LESSONS: This case underscores the importance of accurate genetic diagnosis in the management of MODY and suggests that genetic testing should be considered more broadly in families with a history of diabetes, even when the clinical presentations vary. The identification of different MODY subtypes within a single family not only enhances our understanding of the disease's genetic diversity but also has significant implications for personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.